2.08
price up icon4.00%   0.08
 
loading

Immunitybio Inc Aktie (IBRX) Neueste Nachrichten

pulisher
04:18 AM

Why ImmunityBio Inc. (26CA) stock is upgraded to buyCPI Data & Long-Term Growth Plans - newser.com

04:18 AM
pulisher
02:29 AM

What dividend safety rating applies to ImmunityBio Inc. (26CA) stockRisk Management & Advanced Technical Signal Analysis - newser.com

02:29 AM
pulisher
Nov 14, 2025

Will ImmunityBio's (IBRX) Surging Revenue and Lower Net Loss Shift Its Investment Narrative? - simplywall.st

Nov 14, 2025
pulisher
Nov 14, 2025

Why ImmunityBio Inc. (26CA) stock is a strong analyst pickWeekly Trade Analysis & High Accuracy Investment Entry Signals - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Can machine learning forecast ImmunityBio Inc. recoveryJuly 2025 Review & Risk Controlled Stock Alerts - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Why ImmunityBio Inc. (26CA) stock stays undervaluedJuly 2025 Outlook & Daily Entry Point Alerts - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Intraday pattern recognizer results for ImmunityBio Inc.Analyst Upgrade & Short-Term High Return Strategies - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

How ImmunityBio Inc. (26CA) stock responds to bond marketMarket Rally & Expert-Curated Trade Recommendations - newser.com

Nov 14, 2025
pulisher
Nov 13, 2025

D. Boral Capital Maintains ImmunityBio (IBRX) Buy Recommendation - Nasdaq

Nov 13, 2025
pulisher
Nov 13, 2025

ImmunityBio (IBRX): Assessing Valuation After Q3 Revenue Surge and Narrowed Losses - Yahoo Finance

Nov 13, 2025
pulisher
Nov 13, 2025

Is ImmunityBio Inc. (26CA) stock a buy before earnings resultsChart Signals & Capital Protection Trade Alerts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

ImmunityBio Inc. recovery potential after sell offGDP Growth & Fast Gain Stock Trading Tips - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

How ImmunityBio's (IBRX) Revenue Surge and Narrowed Losses May Affect Investor Outlook - Yahoo Finance

Nov 13, 2025
pulisher
Nov 13, 2025

New Survey Reveals Non-Muscle Invasive Bladder Cancer Patients Seek More Care Conversations - Business Wire

Nov 13, 2025
pulisher
Nov 11, 2025

ImmunityBio Reports Revenue Surge Amid Financial Challenges - TipRanks

Nov 11, 2025
pulisher
Nov 11, 2025

Will Valiant Communications Limited Stock Benefit From Industry Trends in YEAREarnings Growth Projections & Free High Velocity Capital Growth - earlytimes.in

Nov 11, 2025
pulisher
Nov 11, 2025

Will ImmunityBio Inc. (26CA) stock justify high valuationSell Signal & Verified Stock Trade Ideas - newser.com

Nov 11, 2025
pulisher
Nov 11, 2025

Why retail investors favor ImmunityBio Inc. stockQuarterly Investment Review & Community Trade Idea Sharing - newser.com

Nov 11, 2025
pulisher
Nov 11, 2025

Will ImmunityBio Inc. stock continue upward momentumGap Down & Verified Momentum Stock Watchlist - newser.com

Nov 11, 2025
pulisher
Nov 10, 2025

What moving averages say about ImmunityBio Inc.Quarterly Market Summary & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 10, 2025
pulisher
Nov 10, 2025

How ImmunityBio Inc. (26CA) stock compares with tech leaders2025 Year in Review & Stock Portfolio Risk Control - newser.com

Nov 10, 2025
pulisher
Nov 10, 2025

ImmunityBio Inc (26CA.BE) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 10, 2025
pulisher
Nov 07, 2025

ImmunityBio Inc. (IBRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 07, 2025
pulisher
Nov 07, 2025

Revenue per share of ImmunityBio Inc – HAM:26CA - TradingView

Nov 07, 2025
pulisher
Nov 07, 2025

Is ImmunityBio Inc a good long term investmentTechnical Analysis Insights & Swing Trade Smarter With Data Insights - earlytimes.in

Nov 07, 2025
$39.16
price down icon 1.43%
$30.26
price up icon 0.07%
$104.15
price down icon 1.20%
$103.09
price down icon 0.76%
biotechnology ONC
$365.82
price down icon 0.69%
$193.22
price up icon 1.18%
Kapitalisierung:     |  Volumen (24h):